Dang Tran Dat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dang Tran Dat has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Nguyen Duc Anh
BSNT
2 shared publicationsAdrian H.C. Koh
1 shared publication- Akitaka Tsujikawa
Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
1 shared publication - Andrew Chang
Sydney Retina Clinic, Sydney Eye Hospital, University of Sydney, Sydney, NSW, Australia
1 shared publication - Bui Viet Hung
Vitreoretial Department, Vietnam National Eye Hospital, 85 Ba Trieu, Nguyen Du Ward, Hai Ba Trung District, Hanoi 100000, Vietnam
1 shared publication Charles C. Wykoff
1 shared publication
Latest Publications
- Open Access
- 9 October 2026
- Published by Elsevier in Asia-Pacific Journal of Ophthalmology
- Vol. 15 (5)
International consensuses and guidelines on etiology, diagnosis, and treatment of Retinal Vein Occlusion (RVO) by the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO), Asia-Pacific Vitreo-retina Society (APVRS) and Academia Retina Internationalis (ARI)
- 9 October 2026
- Published by Elsevier in Asia-Pacific Journal of Ophthalmology
- Vol. 15 (5)
Open AccessInternational consensuses and guidelines on etiology, diagnosis, and treatment of Retinal Vein Occlusion (RVO) by the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO), Asia-Pacific Vitreo-retina Society (APVRS) and Academia Retina Internationalis (ARI)
- Open Access
- 15 September 2026
- Published by Rangsit University in Journal of Current Science and Technology
- Vol. 16 (4) , 223
Clinical and Optical Coherence Tomography Characteristics of Large Primary Macular Holes
Large primary full-thickness macular holes are associated with visual impairment and complex optical coherence tomography (OCT) abnormalities. This single-center cross-sectional study described pretreatment clinical and OCT characteristics of large primary macular holes and explored associations with symptom duration and visual acuity. Forty eyes from 40 surgical candidates with primary macular holes and a minimum linear diameter (MLD) > 400 µm were analyzed at Vietnam National Eye Hospital, Hanoi, Vietnam, from March to December 2025. Clinical variables included age, sex, symptom duration, and best-corrected visual acuity (BCVA). OCT variables included vitreomacular status, fluid cuff, intraretinal cyst severity, MLD, base diameter, hole height, external limiting membrane (ELM) and ellipsoid zone (EZ) defect lengths, macular thickness parameters, and macular hole indices. Mean age was 63.7 ± 8.4 years, and women accounted for 57.5% of patients. Mean BCVA was 1.47 ± 0.44 logMAR. Mean MLD, base diameter, and hole height were 594.3 ± 155.8 µm, 1234.9 ± 456.3 µm, and 480.3 ± 110.4 µm, respectively. Complete posterior vitreous detachment, fluid cuff, and intraretinal cysts of any severity were observed in 77.5%, 57.5%, and 85.0% of eyes, respectively. Longer symptom duration was associated with larger MLD and lower HFF and THI. Poorer BCVA was associated with larger MLD and lower MHI and THI. Outer retinal defect lengths correlated with hole size, and fluid cuff was associated with wider structural disruption. Comprehensive pretreatment OCT assessment helps characterize structural severity in large primary macular holes. These associations are exploratory and should be validated prospectively.
- 15 September 2026
- Published by Rangsit University in Journal of Current Science and Technology
- Vol. 16 (4) , 223
Open AccessClinical and Optical Coherence Tomography Characteristics of Large Primary Macular Holes
Large primary full-thickness macular holes are associated with visual impairment and complex optical coherence tomography (OCT) abnormalities. This single-center cross-sectional study described pretreatment clinical and OCT characteristics of large primary macular holes and explored associations with symptom duration and visual acuity. Forty eyes from 40 surgical candidates with primary macular holes and a minimum linear diameter (MLD) > 400 µm were analyzed at Vietnam National Eye Hospital, Hanoi, Vietnam, from March to December 2025. Clinical variables included age, sex, symptom duration, and best-corrected visual acuity (BCVA). OCT variables included vitreomacular status, fluid cuff, intraretinal cyst severity, MLD, base diameter, hole height, external limiting membrane (ELM) and ellipsoid zone (EZ) defect lengths, macular thickness parameters, and macular hole indices. Mean age was 63.7 ± 8.4 years, and women accounted for 57.5% of patients. Mean BCVA was 1.47 ± 0.44 logMAR. Mean MLD, base diameter, and hole height were 594.3 ± 155.8 µm, 1234.9 ± 456.3 µm, and 480.3 ± 110.4 µm, respectively. Complete posterior vitreous detachment, fluid cuff, and intraretinal cysts of any severity were observed in 77.5%, 57.5%, and 85.0% of eyes, respectively. Longer symptom duration was associated with larger MLD and lower HFF and THI. Poorer BCVA was associated with larger MLD and lower MHI and THI. Outer retinal defect lengths correlated with hole size, and fluid cuff was associated with wider structural disruption. Comprehensive pretreatment OCT assessment helps characterize structural severity in large primary macular holes. These associations are exploratory and should be validated prospectively.
- Open Access
- 25 June 2024
- Published by Vietnam National University Journal of Science in VNU Journal of Science: Medical and Pharmaceutical Sciences
- Vol. 40 (2)
Clinical Outcomes of Phacoemulsification with Tecnis Eyhance Intraocular Lens Implantation for Management of Cataracts Associated with Posterior Segment Eye Diseases
The study included 35 eyes, 74% of which were female, and patients aged 60 or older accounted for 74.3% of the total. The average axial length of the eye was 22.86 mm. The average intraocular lens power was 22.17 ± 3.18 D. Regarding posterior segment eye diseases of the eyes, 40% of those had open-angle glaucoma, 25.7% of those had pre-retinal membrane, 8.6% of those had diabetic retinopathy, 5.7% of those had age-related macular degeneration, 8.6% of those had closed-angle glaucoma, and 11.4% of those had other retinal diseases. The preoperative uncorrected distance visual acuity was 0.90 ± 0.26 logMar and the best corrected one was 0.85 ± 0.27 logMar. The preoperative uncorrected intermediate visual acuity was 0.86 ± 0.26 logMar. The preoperative uncorrected near vision was 0.82 ± 0.20 logMar. One-month post-operation, the uncorrected distance visual acuity was 0.44 ± 0.17 logMar, the best-corrected one was 0.35 ± 0.18 logMar, the uncorrected intermediate visual acuity was 0.49 ± 0.14 logMar, and the uncorrected near visual acuity was 0.59 ± 0.10 logMar. The number of eyes that differed between high-contrast sensitivity (100%) and low-contrast sensitivity (10%) less than or equal to 3 lines accounted for 80% of the total. The number of eyes that had spherical refraction one-month post-operation ranging from -0.5D to +0.5D accounted for 68.6% of the total. 20/35 eyes (57.1%) had corneal astigmatism less than or equal to 1D. 34/35 eyes (97.1%) had their intraocular lens aligned center to the visual axis. 28/35 eyes (80%) were reported to have no halos or glare. The number of satisfied patients was 26/35 (74.3% of the total).
- 25 June 2024
- Published by Vietnam National University Journal of Science in VNU Journal of Science: Medical and Pharmaceutical Sciences
- Vol. 40 (2)
Open AccessClinical Outcomes of Phacoemulsification with Tecnis Eyhance Intraocular Lens Implantation for Management of Cataracts Associated with Posterior Segment Eye Diseases
The study included 35 eyes, 74% of which were female, and patients aged 60 or older accounted for 74.3% of the total. The average axial length of the eye was 22.86 mm. The average intraocular lens power was 22.17 ± 3.18 D. Regarding posterior segment eye diseases of the eyes, 40% of those had open-angle glaucoma, 25.7% of those had pre-retinal membrane, 8.6% of those had diabetic retinopathy, 5.7% of those had age-related macular degeneration, 8.6% of those had closed-angle glaucoma, and 11.4% of those had other retinal diseases. The preoperative uncorrected distance visual acuity was 0.90 ± 0.26 logMar and the best corrected one was 0.85 ± 0.27 logMar. The preoperative uncorrected intermediate visual acuity was 0.86 ± 0.26 logMar. The preoperative uncorrected near vision was 0.82 ± 0.20 logMar. One-month post-operation, the uncorrected distance visual acuity was 0.44 ± 0.17 logMar, the best-corrected one was 0.35 ± 0.18 logMar, the uncorrected intermediate visual acuity was 0.49 ± 0.14 logMar, and the uncorrected near visual acuity was 0.59 ± 0.10 logMar. The number of eyes that differed between high-contrast sensitivity (100%) and low-contrast sensitivity (10%) less than or equal to 3 lines accounted for 80% of the total. The number of eyes that had spherical refraction one-month post-operation ranging from -0.5D to +0.5D accounted for 68.6% of the total. 20/35 eyes (57.1%) had corneal astigmatism less than or equal to 1D. 34/35 eyes (97.1%) had their intraocular lens aligned center to the visual axis. 28/35 eyes (80%) were reported to have no halos or glare. The number of satisfied patients was 26/35 (74.3% of the total).
- Open Access
- 25 June 2024
- Published by Vietnam National University Journal of Science in VNU Journal of Science: Medical and Pharmaceutical Sciences
- Vol. 40 (2)
Clinical Characteristics of Non-arteritic Anterior Ischaemic Optic Neuropathy and Clinical Outcomes of Systemic Corticosteroid Therapy
Purpose: Describe the clinical characteristics of the disease and preliminarily evaluate the clinical outcomes of systemic corticosteroid therapy for the management of non-arteritic anterior ischaemic optic neuropathy. Methods: This is a cross-sectional descriptive study, conducted on 20 patients examined and treated at Vietnam National Institute of Ophthalmology from March 2021 to December 2023. Outcomes: The study included 20 eyes in 20 patients (8 men and 12 women), the disease mainly started after age 50 (80%). Regarding risk factors for disease onset, 4/20 (20%) patients had a history of vascular disease (diabetes mellitus, hypertension), and 20/20 (100%) patients had a second eye (normal eye) with a crowded, narrow optic disc structure, with no cup. 70% of patients came to the doctor within 1 week of illness and vision below 20/100 accounted for 80%. All patients had an inferior altitudinal defect, with moderate to severe papilledema accounting for 95%. The duration of management with systemic corticosteroids between the time when the disease was detected and when the papilledema withdraws ranging from 1 to 3 weeks (average 2 weeks) accounted for 85%. After 6 months of management, 70% of patients maintained their visual acuity, and 25% of them had their visual acuity increased by 3 rows. 55% of patients preserved their visual field and 35% of them had their visual field improved. Conclusion: Understanding the clinical characteristics helped doctors diagnose, treat, and prognose the disease. The mean duration of using oral corticosteroids at a dose of 48 mg/day was 2 weeks ranging from when the disease was detected to when the papilledema was withdrawn. Although the study did not have a control group, initially it could illustrate that oral corticosteroids had the effect of cutting off the pathological spiral, preventing the progression of the disease, and partially improving vision.
- 25 June 2024
- Published by Vietnam National University Journal of Science in VNU Journal of Science: Medical and Pharmaceutical Sciences
- Vol. 40 (2)
Open AccessClinical Characteristics of Non-arteritic Anterior Ischaemic Optic Neuropathy and Clinical Outcomes of Systemic Corticosteroid Therapy
Purpose: Describe the clinical characteristics of the disease and preliminarily evaluate the clinical outcomes of systemic corticosteroid therapy for the management of non-arteritic anterior ischaemic optic neuropathy. Methods: This is a cross-sectional descriptive study, conducted on 20 patients examined and treated at Vietnam National Institute of Ophthalmology from March 2021 to December 2023. Outcomes: The study included 20 eyes in 20 patients (8 men and 12 women), the disease mainly started after age 50 (80%). Regarding risk factors for disease onset, 4/20 (20%) patients had a history of vascular disease (diabetes mellitus, hypertension), and 20/20 (100%) patients had a second eye (normal eye) with a crowded, narrow optic disc structure, with no cup. 70% of patients came to the doctor within 1 week of illness and vision below 20/100 accounted for 80%. All patients had an inferior altitudinal defect, with moderate to severe papilledema accounting for 95%. The duration of management with systemic corticosteroids between the time when the disease was detected and when the papilledema withdraws ranging from 1 to 3 weeks (average 2 weeks) accounted for 85%. After 6 months of management, 70% of patients maintained their visual acuity, and 25% of them had their visual acuity increased by 3 rows. 55% of patients preserved their visual field and 35% of them had their visual field improved. Conclusion: Understanding the clinical characteristics helped doctors diagnose, treat, and prognose the disease. The mean duration of using oral corticosteroids at a dose of 48 mg/day was 2 weeks ranging from when the disease was detected to when the papilledema was withdrawn. Although the study did not have a control group, initially it could illustrate that oral corticosteroids had the effect of cutting off the pathological spiral, preventing the progression of the disease, and partially improving vision.
- Open Access
- 10 August 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (16) , 4678
Current Trends in Clinical Characteristics, Diagnosis, and Treatment of Polypoidal Choroidal Vasculopathy: A Perspective from Vietnam
Polypoidal choroidal vasculopathy (PCV) is a common choroidal disease in the Asian population including Vietnam and is characterized by subretinal red-orange nodules, pigmented epithelium detachment, and massive subretinal hemorrhage. The recent focus on PCV in Vietnam can be attributed to advancements in PCV diagnosis and treatment. However, there is a scarcity of published literature and clinical data on PCV in the Vietnamese population, highlighting a key knowledge gap in this region. In order to address this gap, we gathered the opinions of experienced clinicians and retinal experts in Vietnam and reviewed available medical literature with the aim of: (i) providing an overview of PCV in the Vietnamese population—in terms of epidemiology, clinical characteristics, and management; (ii) tailoring international/national guidelines for the diagnosis and management of PCV, in line with available resources and medical equipment in Vietnam; and (iii) identifying gaps in clinical data in order to guide future PCV research in Vietnam and other countries with similar clinical conditions. The present review will enable healthcare providers and researchers to gain insight into current clinical practices and the limitations of PCV management in Vietnam and provide optimal and effective solutions.
- 10 August 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (16) , 4678
Open AccessCurrent Trends in Clinical Characteristics, Diagnosis, and Treatment of Polypoidal Choroidal Vasculopathy: A Perspective from Vietnam
Polypoidal choroidal vasculopathy (PCV) is a common choroidal disease in the Asian population including Vietnam and is characterized by subretinal red-orange nodules, pigmented epithelium detachment, and massive subretinal hemorrhage. The recent focus on PCV in Vietnam can be attributed to advancements in PCV diagnosis and treatment. However, there is a scarcity of published literature and clinical data on PCV in the Vietnamese population, highlighting a key knowledge gap in this region. In order to address this gap, we gathered the opinions of experienced clinicians and retinal experts in Vietnam and reviewed available medical literature with the aim of: (i) providing an overview of PCV in the Vietnamese population—in terms of epidemiology, clinical characteristics, and management; (ii) tailoring international/national guidelines for the diagnosis and management of PCV, in line with available resources and medical equipment in Vietnam; and (iii) identifying gaps in clinical data in order to guide future PCV research in Vietnam and other countries with similar clinical conditions. The present review will enable healthcare providers and researchers to gain insight into current clinical practices and the limitations of PCV management in Vietnam and provide optimal and effective solutions.